GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Green Planet Bioengineering Co Ltd (OTCPK:GPLB) » Definitions » Interest Expense

Green Planet Bioengineering Co (Green Planet Bioengineering Co) Interest Expense : $0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Green Planet Bioengineering Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Green Planet Bioengineering Co's interest expense for the three months ended in Mar. 2024 was $ 0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Green Planet Bioengineering Co's Operating Income for the three months ended in Mar. 2024 was $ -0.01 Mil. Green Planet Bioengineering Co's Interest Expense for the three months ended in Mar. 2024 was $ 0.00 Mil. Green Planet Bioengineering Co has no long-term debt (1). The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

(1) Note: An indication of "no long-term debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.


Green Planet Bioengineering Co Interest Expense Historical Data

The historical data trend for Green Planet Bioengineering Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Green Planet Bioengineering Co Interest Expense Chart

Green Planet Bioengineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Green Planet Bioengineering Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Green Planet Bioengineering Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Green Planet Bioengineering Co  (OTCPK:GPLB) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Green Planet Bioengineering Co's Interest Expense for the three months ended in Mar. 2024 was $0.00 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-0.01 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $0.00 Mil.

Green Planet Bioengineering Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Green Planet Bioengineering Co had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Green Planet Bioengineering Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.


Green Planet Bioengineering Co (Green Planet Bioengineering Co) Business Description

Traded in Other Exchanges
N/A
Address
20807 Biscayne Boulevard, Suite 203, Aventura, FL, USA, 33180
Green Planet Bioengineering Co Ltd is a shell company.
Executives
Shanyan Ou director, officer: VP of Sales 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Jian Chen director, officer: Chief Scientist 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Jianrong Zheng director 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Zhao 10 percent owner, officer: CHIEF EXECUTIVE OFFICER 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Min Yan Zhen 10 percent owner 18851 NE 29TH AVENUE, SUITE 700, AVENTURA FL 33180
Cris Neely director, 10 percent owner, officer: President 18851 NE 29TH AVENUE, SUITE 700, AVENTURA CA 33180
Mondo Management Corp. 10 percent owner 61 BROADWAY, NEW YORK NY 10006
Gregory Sichenzia director, 10 percent owner SICHENZIA ROSS FRIEDMAN FERENCE LLP, 1065 AVENUE OF THE AMERICAS, 21ST FLOOR, NEW YORK NY 10018
Darrin M Ocasio director, 10 percent owner, officer: President C/O MONDO ACQUISITION II, 61 BROADWAY, 32ND FLOOR, NEW YORK NY 10006
Michael H Ference director, 10 percent owner, officer: Secretary C/O MONDO ACQUISITION II, 61 BROADWAY, 32ND FLOOR, NEW YORK NY 10006

Green Planet Bioengineering Co (Green Planet Bioengineering Co) Headlines

No Headlines